Transferrin-bound iron in serum
Total Iron blood testing measures the amount of iron circulating in the liquid part of your blood, almost all of it carried by the transport protein transferrin. This circulating iron comes from two sources: iron absorbed from food in the small intestine and iron recycled from worn‑out red blood cells by cleanup cells in the spleen and liver (macrophages). Once released into the bloodstream, iron is loaded onto transferrin and delivered to tissues that need it. This test captures that transferrin‑bound iron in serum (serum iron, total iron), not the iron locked inside red cells as hemoglobin or stored in ferritin/hemosiderin.
Iron's central job is to enable oxygen transport and energy production. Tissues depend on a steady flow of transferrin‑delivered iron to build hemoglobin and to run key enzymes in mitochondria and DNA synthesis (cytochromes, ribonucleotide reductase). A total iron result reflects the immediate supply of usable iron available to the bone marrow and other organs at that moment, showing the dynamic balance between absorption, recycling, storage release, and use. It is often considered alongside measures of transferrin's carrying capacity and iron stores (TIBC/transferrin, ferritin) to frame iron availability.
Snapshot of oxygen-carrying capacity in motion
The Iron, Total blood test estimates how much iron is circulating in your bloodstream at that moment, mostly bound to transferrin. Because iron powers hemoglobin, mitochondrial energy production, thyroid enzymes, and immune responses, this snapshot reflects how well your body can deliver oxygen, make DNA, and fuel cells across organs.
The Iron, Total blood test (serum iron) measures the amount of iron circulating in plasma, mostly bound to transferrin. It reflects the immediate supply of iron for hemoglobin production and iron-dependent enzymes that drive oxygen transport, mitochondrial energy production, neurotransmitter synthesis, thyroid and reproductive function, and immune responses.
Reading serum iron across the deficiency–overload spectrum
Most labs define a normal range that varies slightly by age and sex, with men tending higher than women. In general, feeling and function are best when values sit in the middle of the range and align with normal ferritin and transferrin saturation, since iron balance depends on storage and transport, not just the serum number.
When values are low, it often reflects limited available iron or iron being locked away by inflammation via hepcidin. The bone marrow struggles to build red cells (microcytic anemia), leading to fatigue, shortness of breath with exertion, headaches, brain fog, cold hands, restless legs, hair shedding, and brittle nails. Children and teens may see attention and growth impacts. In pregnancy, low availability strains maternal energy and fetal development.
Low values usually reflect insufficient available iron for red blood cell formation due to depleted stores (iron deficiency) or iron being held in storage during inflammation via hepcidin (anemia of chronic disease). They are common in menstruating and pregnant individuals and during rapid growth. System effects include fatigue, reduced aerobic capacity, cognitive fog, and, if prolonged, smaller, paler red cells (microcytic, hypochromic anemia).
Being in range suggests iron transport matches demand, supporting stable erythropoiesis, steady energy metabolism, and normal cognitive and immune function. Because serum iron fluctuates during the day, within reference ranges status typically aligns with mid-range values when ferritin and transferrin saturation are also normal, indicating balanced iron stores and delivery.
When values are high, it can signal iron overload (such as hereditary hemochromatosis), liver injury releasing iron, reduced transferrin, or a recent iron-rich meal. Excess iron drives oxidative stress, harming the liver, pancreas, heart, joints, and skin, with abdominal discomfort, joint pains, arrhythmias, bronze discoloration, and diabetes over time.
High values usually reflect excess circulating iron from increased absorption or overload (e.g., hereditary causes), release from cell injury or hemolysis, recent iron administration, or ineffective red cell production. System effects relate to oxidative stress with potential liver, cardiac, endocrine, and joint involvement; risk is higher in men and after menopause.
Why a single serum iron number is rarely enough
Serum iron varies with time of day, fasting status, recent iron intake, pregnancy, oral contraceptives, inflammation, and acute illness. Hemolyzed samples can artifactually elevate results. Interpretation is stronger when considered with TIBC, transferrin saturation, and ferritin.
One piece of the iron economy
Big picture: serum iron is one piece of the iron economy. Interpreted with ferritin, TIBC/transferrin, saturation, and a CBC, it connects oxygen transport, metabolism, and immunity to long-term risks like anemia, exercise intolerance, adverse pregnancy outcomes, or, on the other side, cirrhosis, cardiomyopathy, and endocrine dysfunction.
FAQs
It measures circulating iron in serum, mainly bound to transferrin. Best interpreted with ferritin, TIBC, and transferrin saturation.
To detect iron deficiency or overload, track oxygen delivery, and guide nutrition, supplementation, or therapy.
Every 1–3 months during supplementation, training stress, or life stage changes. Occasionally for baseline tracking.
Recent supplements, time of day, inflammation, infection, menstruation, pregnancy, endurance exercise, or liver health.
A morning draw is appropriate. Avoid iron supplements 24 hours before and keep testing conditions consistent.
Superpower currently offers at-home blood testing in the following states: Alabama, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Kansas, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, and Wisconsin.
We’re actively expanding nationwide, with new states being added regularly. If your state isn’t listed yet, stay tuned.
References
- Lopez, A., Cacoub, P., Macdougall, I. C., & Peyrin-Biroulet, L. (2016). Iron deficiency anaemia. Lancet, 387(10021), 907-916. https://doi.org/10.1016/S0140-6736(15)60865-0
- Camaschella, C. (2015). Iron-deficiency anemia. The New England Journal of Medicine, 372(19), 1832-1843. https://doi.org/10.1056/NEJMra1401038
- Cappellini, M. D., Musallam, K. M., & Taher, A. T. (2020). Iron deficiency anaemia revisited. Journal of Internal Medicine, 287(2), 153-170. https://doi.org/10.1111/joim.13004
- Weiss, G., Ganz, T., & Goodnough, L. T. (2019). Anemia of inflammation. Blood, 133(1), 40-50. https://doi.org/10.1182/blood-2018-06-856500
- Ritchie, R. F., Palomaki, G. E., Neveux, L. M., Navolotskaia, O., Ledue, T. B., & Craig, W. Y. (2002). Reference distributions for serum iron and transferrin saturation: a practical, simple, and clinically relevant approach in a large cohort. Journal of Clinical Laboratory Analysis, 16(5), 237-245. https://doi.org/10.1002/jcla.10048






































.avif)
